Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
暂无分享,去创建一个
Marja Rissanen | Benedikt Weber | Thorsten Deichmann | Anita Driessen-Mol | Simon P. Hoerstrup | Frank P. T. Baaijens | Maximilian Y. Emmert | Dörthe Schmidt | F. Baaijens | S. Hoerstrup | M. Emmert | A. Driessen-Mol | G. Zund | D. Schmidt | B. Weber | Petra E. Dijkman | Gregor Zund | Bernhard Odermatt | P. Dijkman | Marja Rissanen | A. Puolakka | Rene Stenger | Christine Mariani | Arja Puolakka | B. Odermatt | R. Stenger | T. Deichmann | Christine Mariani | Bernhard Odermatt
[1] U. Stock,et al. Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves. , 2006, The Journal of thoracic and cardiovascular surgery.
[2] Improved regional wall motion 6 months after direct myocardial revascularization (DMR) with the NOGA DMR system. , 2000, Circulation.
[3] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[4] Anita Mol,et al. Hypoxia Induces Near-Native Mechanical Properties in Engineered Heart Valve Tissue , 2009, Circulation.
[5] S. Hoerstrup,et al. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. , 2006, Tissue engineering.
[6] Anson Cheung,et al. Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience , 2006, Circulation.
[7] Simon P. Hoerstrup,et al. Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.
[8] Younes Boudjemline,et al. Percutaneous insertion of the pulmonary valve. , 2002, Journal of the American College of Cardiology.
[9] F. Schoen,et al. Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.
[10] Simon P Hoerstrup,et al. Living Autologous Heart Valves Engineered From Human Prenatally Harvested Progenitors , 2006, Circulation.
[11] F. Naftolin,et al. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. , 1980, Analytical biochemistry.
[12] Philipp Bonhoeffer,et al. NEW PERCUTANEOUS TREATMENTS FOR VALVE DISEASE , 2007, Heart.
[13] Mirko Doss,et al. Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.
[14] J. Hoffman,et al. The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.
[15] Michael S Sacks,et al. From Stem Cells to Viable Autologous Semilunar Heart Valve , 2005, Circulation.
[16] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[17] C. Bolognesi,et al. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. , 1979, Analytical biochemistry.
[18] Reza Ardehali,et al. Percutaneous valve replacement: current state and future prospects. , 2004, The Annals of thoracic surgery.
[19] Marcel C M Rutten,et al. A physiologically representative in vitro model of the coronary circulation. , 2004, Physiological measurement.
[20] Assaf Bash,et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.
[21] F. Schoen,et al. Human Pulmonary Valve Progenitor Cells Exhibit Endothelial/Mesenchymal Plasticity in Response to Vascular Endothelial Growth Factor-A and Transforming Growth Factor-&bgr;2 , 2006, Circulation research.
[22] Frederick J. Schoen,et al. Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves , 2000, Circulation.
[23] Marcel C. M. Rutten,et al. Tissue Engineering of Human Heart Valve Leaflets: A Novel Bioreactor for a Strain-Based Conditioning Approach , 2005, Annals of Biomedical Engineering.
[24] Frank P T Baaijens,et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. , 2005, Biomaterials.
[25] E. Ohman,et al. Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes. , 2007, Circulation.
[26] J E Mayer,et al. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. , 2000, Tissue engineering.
[27] S. Hoerstrup,et al. Prenatally Fabricated Autologous Human Living Heart Valves Based on Amniotic Fluid–Derived Progenitor Cells as Single Cell Source , 2007, Circulation.
[28] Marcel C M Rutten,et al. Autologous Human Tissue-Engineered Heart Valves: Prospects for Systemic Application , 2006, Circulation.
[29] F J Schoen,et al. Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.
[30] Artur Lichtenberg,et al. Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells , 2006, Circulation.
[31] D. Buttle,et al. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.
[32] John E Mayer,et al. Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector. , 2006, Tissue engineering.
[33] Frederick J. Schoen,et al. Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.
[34] Paul Khairy,et al. Bicuspid aortic valve morphology and interventions in the young. , 2007, Journal of the American College of Cardiology.